PanFeng Feng

6PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2026
Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.

|Apr 16, 2026
Cycloastragenol Inhibits Colorectal Cancer Cell Metastasis via Epithelial-Mesenchymal Transition and the PI3K Signalling Pathway.

|Dec 22, 2025
Socazolimab combined with carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis in China.

Lian Tang, Yong Chen, Shaoqing Zhan

|Dec 17, 2024
Xuebijing and somatostatin against acute pancreatitis: A systematic review and network pharmacology.

Ji-Ping Cao, Xiang-Hua Piao, Long-Xun Zhu

|Sep 27, 2024
RETRACTED: Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.

Xiang-Fan Chen, Pei-Gen Liu, Nan Sheng

Pageof 1

Frequent Collaborators

1 joint publications

Nan Sheng

1 joint publications

Wenwen Wang

1 joint publications

Yingying Gao

1 joint publications

Xiaoxiang Chen